Subendocardial systolic dysfunction in asymptomatic normotensive diabetic patients

Circulation Journal

Volumn 79, Issue 8, 2015, Pages 1749-1755

  Enomoto, Mami ^a   Ishizu, Tomoko ^a,b   Seo, Yoshihiro ^a   Yamamoto, Masayoshi ^a   Suzuki, Hiroaki ^b   Shimano, Hitoshi ^b   Kawakami, Yasushi ^b   Aonuma, Kazutaka ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Diabetic cardiomyopathy; Longitudinal strain; Subendocardial dysfunction

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR PARAMETERS; CLINICAL ASSESSMENT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; HUMAN; LEFT ATRIAL VOLUME INDEX; LEFT VENTRICULAR MASS INDEX; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFUSION IMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; REPRODUCIBILITY; SYSTOLIC DYSFUNCTION; AGED; BLOOD; BLOOD PRESSURE; CARDIAC MUSCLE; DIABETIC CARDIOMYOPATHY; HYPERTENSION; METABOLISM; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; OBESITY;

EID: 84937908073     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-15-0012     Document Type: Article

References (22)

1. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: The Framingham study. Am J Cardiol 1974; 34: 29-34.
2. Bando YK, Murohara T. Diabetes-related heart failure. Circ J 2014; 78: 576-583.
3. Authors/Task Force Members, Ryden L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, et al. ESC Guidelines on diabetes, prediabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 2013; 34: 3035-3087.
4. Aguilar D, Deswal A, Ramasubbu K, Mann DL, Bozkurt B. Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus. Am J Cardiol 2010; 105: 373-377.
5. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation 2007; 115: 3213-3223.
6. Ishizu T, Seo Y, Enomoto Y, Sugimori H, Yamamoto M, Machino T, et al. Experimental validation of left ventricular transmural strain gradient with echocardiographic two-dimensional speckle tracking imaging. Eur J Echocardiogr 2010; 11: 377-385.
7. Fujihara K, Suzuki H, Sato A, Ishizu T, Kodama S, Heianza Y, et al. Comparison of the Framingham risk score, UK Prospective Diabetes Study (UKPDS) Risk Engine, Japanese Atherosclerosis Longitudinal Study-Existing Cohorts Combine (JALS-ECC) and maximum carotid intima-media thickness for predicting coronary artery stenosis in patients with asymptomatic type 2 diabetes. J Atheroscler Thromb 2014; 21: 799-815.
8. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
9. Seo Y, Ishimitsu T, Ishizu T, Obara K, Moriyama N, Kawano S, et al. Assessment of propagation velocity by contrast echocardiography for standardization of color Doppler propagation velocity measurements. J Am Soc Echocardiogr 2004; 17: 1266-1274.
10. Ishizu T, Seo Y, Baba M, Machino T, Higuchi H, Shiotsuka J, et al. Impaired subendocardial wall thickening and post-systolic shortening are signs of critical myocardial ischemia in patients with flow-limiting coronary stenosis. Circ J 2011; 75: 1934-1941.
11. Streeter DD Jr, Spotnitz HM, Patel DP, Ross J Jr, Sonnenblick EH. Fiber orientation in the canine left ventricle during diastole and systole. Circ Res 1969; 24: 339-347.
12. Ernande L, Rietzschel ER, Bergerot C, De Buyzere ML, Schnell F, Groisne L, et al. Impaired myocardial radial function in asymptomatic patients with type 2 diabetes mellitus: A speckle-tracking imaging study. J Am Soc Echocardiogr 2010; 23: 1266-1272.
13. Ma H, Xie M, Wang J, Lu Q, Wang X, Lu X, et al. Ultrasound speckle tracking imaging contributes to early diagnosis of impaired left ventricular systolic function in patients with type 2 diabetes mellitus. J Huazhong Univ Sci Technol Med Sci 2008; 28: 719-723.
14. Ng AC, Delgado V, Bertini M, van der Meer RW, Rijzewijk LJ, Shanks M, et al. Findings from left ventricular strain and strain rate imaging in asymptomatic patients with type 2 diabetes mellitus. Am J Cardiol 2009; 104: 1398-1401.
15. Nakai H, Takeuchi M, Nishikage T, Lang RM, Otsuji Y. Subclinical left ventricular dysfunction in asymptomatic diabetic patients assessed by two-dimensional speckle tracking echocardiography: Correlation with diabetic duration. Eur J Echocardiogr 2009; 10: 926-932.
16. Boyer JK, Thanigaraj S, Schechtman KB, Perez JE. Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol 2004; 93: 870-875.
17. Ishizu T, Seo Y, Kameda Y, Kawamura R, Kimura T, Shimojo N, et al. Left ventricular strain and transmural distribution of structural remodeling in hypertensive heart disease. Hypertension 2014; 63: 500-506.
18. Mizuguchi Y, Oishi Y, Miyoshi H, Iuchi A, Nagase N, Oki T. Concentric left ventricular hypertrophy brings deterioration of systolic longitudinal, circumferential, and radial myocardial deformation in hypertensive patients with preserved left ventricular pump function. J Cardiol 2010; 55: 23-33.
19. Kishi S, Armstrong AC, Gidding SS, Colangelo LA, Venkatesh BA, Jacobs DR Jr, et al. Association of obesity in early adulthood and middle age with incipient left ventricular dysfunction and structural remodeling: The CARDIA study (Coronary Artery Risk Development in Young Adults). JACC Heart Fail 2014; 2: 500-508.
20. Shigeta T, Aoyama M, Bando YK, Monji A, Mitsui T, Takatsu M, et al. Dipeptidyl peptidase-4 modulates left ventricular dysfunction in chronic heart failure via angiogenesis-dependent and -independent actions. Circulation 2012; 126: 1838-1851.
21. Wang TJ, Larson MG, Keyes MJ, Levy D, Benjamin EJ, Vasan RS. Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals. Circulation 2007; 115: 1345-1353.
22. Oyama J, Node K. Incretin therapy and heart failure. Circ J 2014; 78: 819-824.